Press Alert: Boehringer Ingelheim to Raise Awareness of Women in Cardiovascular Disease and Thrombosis

02/09/2013 - 10:10

For media outside of the US, the UK & Canada only

What: Join key experts in cardiology and thrombosis for a special TweetChat (#ChatAFib), live from the ESC Congress 2013 (#ESCcongress2013) in Amsterdam, which is organised by the European Society of Cardiology

We will be discussing:

Key issues around awareness of cardiovascular disease and thrombosis in women
How common is antithrombotic treatment use in women versus men?
Are women more likely than men to become disabled by an AF-related stroke?
Management of women, cardiovascular disease and thrombosis in daily clinical practice

Who:

Prof. Angela Maas, Professor of Cardiology for Women, UMC, St. Radboud, The Netherlands
Dr. Yolande Appelman, Chair of the Working Group on Gender, The Netherlands Society of Cardiology and Interventional Cardiologist at VUmc
Patient Advocacy Group representatives including Mellanie True Hills from StopAFib.org and De Hart & Vaatgroep

When: 15:00 - 16:00 CET, Monday 2nd September

How: This is a bilingual TweetChat. To join the conversation in English follow #ChatAFib, to join the conversation in Dutch follow #Hartenvaat

On Twitter

Follow @boehringer and @boehringernl for updates and information

Photos/Multimedia Gallery Available: http://www.businesswire.com/multimedia/home/20130830005338/en/